In the present study, we demonstrated significant elevations of plasma NfL and phosphorylated tau at threonine 181 (p-tau181) in patients with DM1, supporting their potential as circulating indicators of CNS pathology. The gene discussed is MAPT; the disease is myotonic dystrophy type 1.